{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:28:13Z","timestamp":1793327293150,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007110","name":"Schering-Plough","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1053\/j.gastro.2012.01.030","type":"journal-article","created":{"date-parts":[[2012,1,25]],"date-time":"2012-01-25T12:58:22Z","timestamp":1327496302000},"page":"1132-1139.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Risk for Immune-Mediated Graft Dysfunction in Liver Transplant Recipients With Recurrent HCV Infection Treated With Pegylated Interferon"],"prefix":"10.1053","volume":"142","author":[{"given":"Josh","family":"Levitsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Fiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Norvell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kymberly D.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Tewani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"McCashland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarouf A.","family":"Hoteit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Shaked","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2012.01.030_bib1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C infection after liver transplantation","volume":"334","author":"Gane","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2012.01.030_bib2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.510290122","article-title":"High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes","volume":"29","author":"Prieto","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.01.030_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2012.01.030_bib4","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1600-6143.2006.01362.x","article-title":"Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis","volume":"6","author":"Wang","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1053\/j.gastro.2012.01.030_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1478-3231.2005.1065.x","article-title":"Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation","volume":"25","author":"Yedibela","year":"2005","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2012.01.030_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/0003-4819-116-1-51","article-title":"Autoimmune chronic hepatitis exacerbated by alpha-interferon","volume":"116","author":"Papo","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2012.01.030_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/eje.0.1320587","article-title":"Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a","volume":"132","author":"Preziati","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.gastro.2012.01.030_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gut.2006.092064","article-title":"High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?","volume":"56","author":"Berardi","year":"2007","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2012.01.030_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/lt.20706","article-title":"Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation","volume":"12","author":"Kontorinis","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2012.01.030_bib10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/lt.21447","article-title":"Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus","volume":"14","author":"Fiel","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2012.01.030_bib11","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/lt.21949","article-title":"Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant","volume":"15","author":"Ward","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2012.01.030_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.tp.0000269609.08495.45","article-title":"Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin","volume":"84","author":"Stanca","year":"2007","journal-title":"Transplantation"},{"key":"10.1053\/j.gastro.2012.01.030_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhep.2010.11.012","article-title":"Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients","volume":"55","author":"Selzner","year":"2011","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2012.01.030_bib14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510310337","article-title":"Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection","volume":"31","author":"Demetris","year":"2000","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.01.030_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: an international consensus document","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.01.030_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2307\/2531021","article-title":"Sample-size formula for the proportional-hazards regression model","volume":"39","author":"Schoenfeld","year":"1983","journal-title":"Biometrics"},{"key":"10.1053\/j.gastro.2012.01.030_bib17","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/lt.20737","article-title":"Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C","volume":"12","author":"Berenguer","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2012.01.030_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jhep.2006.10.017","article-title":"Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation","volume":"46","author":"Picciotto","year":"2007","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2012.01.030_bib19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1600-6143.2007.02126.x","article-title":"Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation","volume":"8","author":"Berenguer","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1053\/j.gastro.2012.01.030_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.2005.029348","article-title":"Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation","volume":"59","author":"Hofer","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.gastro.2012.01.030_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.01.030_bib22","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/hep.23504","article-title":"Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials","volume":"51","author":"Awad","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.01.030_bib23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/jhep.2002.31726","article-title":"Histologic and biochemical changes during the evolution of chronic rejection of liver allografts","volume":"35","author":"Neil","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.01.030_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00007890-199402000-00009","article-title":"Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation","volume":"57","author":"Shiffman","year":"1994","journal-title":"Transplantation"},{"key":"10.1053\/j.gastro.2012.01.030_bib25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2006.01.005","article-title":"Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression","volume":"44","author":"Berenguer","year":"2006","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2012.01.030_bib26","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/gast.2002.36045","article-title":"Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C","volume":"123","author":"Kamal","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2012.01.030_bib27","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0016-5085(99)70352-5","article-title":"Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation","volume":"117","author":"Rosen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2012.01.030_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1872-034X.2010.00734.x","article-title":"Hepatitis C virus-specific CD8+ T cell frequencies are associated with the responses of pegylated interferon-alpha and ribavirin combination therapy in patients with chronic hepatitis C virus infection","volume":"41","author":"Tatsumi","year":"2011","journal-title":"Hepatol Res"},{"key":"10.1053\/j.gastro.2012.01.030_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/hep.20507","article-title":"Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation","volume":"41","author":"Weston","year":"2005","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.01.030_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1021759120428","article-title":"Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature","volume":"48","author":"Tahan","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2012.01.030_bib31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/gast.1997.v112.pm9041265","article-title":"New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine","volume":"112","author":"Tilg","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2012.01.030_bib32","first-page":"210","article-title":"Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C","volume":"23","author":"Larrea","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.01.030_fr1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/lt.21447","article-title":"Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus","volume":"14","author":"Fiel","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2012.01.030_fr2","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/lt.21949","article-title":"Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant","volume":"15","author":"Ward","year":"2009","journal-title":"Liver Transpl"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508512001473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508512001473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:39:03Z","timestamp":1762162743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508512001473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0016508512001473"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2012.01.030","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk for Immune-Mediated Graft Dysfunction in Liver Transplant Recipients With Recurrent HCV Infection Treated With Pegylated Interferon","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2012.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}